Demant A/S

LSE:0RGT Stock Report

Market Cap: kr.68.1b

Demant Valuation

Is 0RGT undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

5/6

Valuation Score 5/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Earnings vs Peers

  • Price-To-Earnings vs Industry

  • Price-To-Earnings vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of 0RGT when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: 0RGT (DKK313.2) is trading below our estimate of fair value (DKK635.16)

Significantly Below Fair Value: 0RGT is trading below fair value by more than 20%.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for 0RGT?

Other financial metrics that can be useful for relative valuation.

0RGT key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Key Statistics
Enterprise Value/Revenue3.6x
Enterprise Value/EBITDA17.3x
PEG Ratio2.1x

Price to Earnings Ratio vs Peers

How does 0RGT's PE Ratio compare to its peers?

The above table shows the PE ratio for 0RGT vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PEEstimated GrowthMarket Cap
Peer Average45.4x
SN. Smith & Nephew
41.6x21.7%UK£8.7b
NIOX NIOX Group
31.3x16.7%UK£297.6m
CTEC ConvaTec Group
51.1x20.6%UK£5.3b
EKF EKF Diagnostics Holdings
57.7x35.3%UK£135.7m
0RGT Demant
26.7x12.6%kr.68.1b

Price-To-Earnings vs Peers: 0RGT is good value based on its Price-To-Earnings Ratio (26.7x) compared to the peer average (45.4x).

Price to Earnings Ratio vs Industry

How does 0RGT's PE Ratio compare vs other companies in the European Medical Equipment Industry?

0 CompaniesPrice / EarningsEstimated GrowthMarket Cap
Industry Avg.n/a21.6%
 n/an/an/a
No. of CompaniesPE048121620

Fetching data

0 CompaniesPrice / EarningsEstimated GrowthMarket Cap
Industry Avg.n/a21.6%
 n/an/an/a
No more companies

Price-To-Earnings vs Industry: 0RGT is good value based on its Price-To-Earnings Ratio (26.7x) compared to the European Medical Equipment industry average (31.6x).

Price to Earnings Ratio vs Fair Ratio

What is 0RGT's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

0RGT PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio26.7x
Fair PE Ratio40.6x

Price-To-Earnings vs Fair Ratio: 0RGT is good value based on its Price-To-Earnings Ratio (26.7x) compared to the estimated Fair Price-To-Earnings Ratio (40.6x).

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst 0RGT forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
Currentkr.313.20
kr.334.13
+6.7%
15.7%kr.400.00kr.240.00n/a16
Apr ’25kr.341.68
kr.339.47
-0.6%
15.8%kr.405.00kr.240.00n/a17
Mar ’25kr.349.69
kr.336.53
-3.8%
15.1%kr.400.00kr.240.00n/a17
Feb ’25kr.314.69
kr.298.71
-5.1%
13.5%kr.355.00kr.235.00n/a17
Jan ’25kr.296.00
kr.288.71
-2.5%
15.1%kr.350.00kr.185.00n/a17
Dec ’24kr.284.00
kr.286.76
+1.0%
13.4%kr.335.00kr.185.00n/a17
Nov ’24kr.269.28
kr.287.69
+6.8%
15.4%kr.340.00kr.185.00n/a16
Oct ’24kr.295.57
kr.286.47
-3.1%
15.8%kr.340.00kr.185.00n/a15
Sep ’24kr.285.20
kr.285.94
+0.3%
15.4%kr.340.00kr.185.00n/a16
Aug ’24kr.266.30
kr.264.27
-0.8%
19.1%kr.330.00kr.180.00n/a15
Jul ’24kr.288.53
kr.256.60
-11.1%
20.2%kr.330.00kr.180.00n/a15
Jun ’24kr.269.55
kr.252.13
-6.5%
20.9%kr.330.00kr.180.00n/a15
May ’24kr.289.40
kr.230.79
-20.3%
19.4%kr.330.00kr.180.00kr.321.6014
Apr ’24kr.238.75
kr.222.00
-7.0%
13.2%kr.275.00kr.180.00kr.341.6813
Mar ’24kr.209.93
kr.218.00
+3.8%
14.8%kr.275.00kr.180.00kr.349.6914
Feb ’24kr.198.06
kr.206.50
+4.3%
13.7%kr.254.00kr.170.00kr.314.6914
Jan ’24kr.193.28
kr.215.23
+11.4%
16.7%kr.285.00kr.165.00kr.296.0013
Dec ’23kr.206.20
kr.215.25
+4.4%
17.2%kr.285.00kr.165.00kr.284.0012
Nov ’23kr.207.71
kr.249.08
+19.9%
19.9%kr.330.00kr.176.00kr.269.2812
Oct ’23kr.183.27
kr.270.36
+47.5%
13.2%kr.330.00kr.200.00kr.295.5711
Sep ’23kr.221.80
kr.278.09
+25.4%
10.0%kr.330.00kr.232.00kr.285.2011
Aug ’23kr.276.09
kr.308.09
+11.6%
12.3%kr.375.00kr.232.00kr.266.3011
Jul ’23kr.268.80
kr.317.45
+18.1%
14.7%kr.390.00kr.232.00kr.288.5311
Jun ’23kr.306.45
kr.308.46
+0.7%
16.6%kr.390.00kr.225.00kr.269.5513
May ’23kr.312.70
kr.304.64
-2.6%
16.7%kr.390.00kr.225.00kr.289.4014

Analyst Forecast: Target price is less than 20% higher than the current share price.

Discover undervalued companies

7D

1Y

7D

1Y

7D

1Y

Simply Wall St™
Simply Wall Street Pty Ltd
Level 7, 320 Pitt Street, Sydney
Download on the App StoreGet it on Google Play
Popular Markets
USAUUKINCAZA
About UsCareersPlansLogin
Help CenterLatest CoveragePodcastsAffiliate ProgramBusiness & Enterprise
Financial Services GuideTerms and ConditionsPrivacy PolicyLogos provided by Clearbit
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.